Skip to content
Announcement:

Our latest paper in collaboration with Pfizer on the role of OCT2/MATE in creatinine clearance is accepted in JPET.

3rd Annual Gene Therapy for Ophthalmic Disorders

Date

3rd October 2023 - 5 October, 2023

Venue

TBC

Location

Boston, MA

The 3rd Annual Gene Therapy for Ophthalmic Disorders meeting brings world class content, bringing two tracks of learning to tackle the pressing challenges faced in the pre-clinical stages and in clinical development. This includes challenges faces with drug targets including wet AMD, dry AMD, DME, IRDs and more.

Find out more

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

Transparent annual Gene Therapy Conference banner.

Get our latest updates straight to your inbox